These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 21198257

  • 1. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
    Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang Y, Wiangnon S, Sripa B, Hong ST.
    Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
    [Abstract] [Full Text] [Related]

  • 2. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
    Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB.
    J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
    [Abstract] [Full Text] [Related]

  • 3. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):873-5. PubMed ID: 16788161
    [Abstract] [Full Text] [Related]

  • 4. Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Matull WR, Khan SA, Pereira SP.
    J Natl Cancer Inst; 2007 Mar 07; 99(5):407; author reply 407-8. PubMed ID: 17341733
    [No Abstract] [Full Text] [Related]

  • 5. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar 07; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 6. Cholangiocarcinoma miscoding in hepatobiliary centres.
    Selvadurai S, Mann K, Mithra S, Bridgewater J, Malik H, Khan SA.
    Eur J Surg Oncol; 2021 Mar 07; 47(3 Pt B):635-639. PubMed ID: 33032867
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA.
    J Hepatol; 2020 Jan 07; 72(1):95-103. PubMed ID: 31536748
    [Abstract] [Full Text] [Related]

  • 9. Impact of changes in the topographic classification of Klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: A population-based national cancer registry study.
    Kang MJ, Lim J, Han SS, Park HM, Kim SW, Won YJ, Park SJ.
    J Hepatobiliary Pancreat Sci; 2021 Sep 07; 28(9):740-750. PubMed ID: 33615747
    [Abstract] [Full Text] [Related]

  • 10. [Pathology of cholangiocarcinoma].
    Guedj N, Bedossa P, Paradis V.
    Ann Pathol; 2010 Dec 07; 30(6):455-63. PubMed ID: 21167432
    [Abstract] [Full Text] [Related]

  • 11. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
    Tyson GL, Ilyas JA, Duan Z, Green LK, Younes M, El-Serag HB, Davila JA.
    Dig Dis Sci; 2014 Dec 07; 59(12):3103-10. PubMed ID: 25204668
    [Abstract] [Full Text] [Related]

  • 12. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A, Wittekind C.
    Internist (Berl); 2004 Jan 07; 45(1):33-41. PubMed ID: 14735242
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
    Al Mahjoub A, Bouvier V, Menahem B, Bazille C, Fohlen A, Alves A, Mulliri A, Launoy G, Lubrano J.
    Eur J Gastroenterol Hepatol; 2019 Jun 07; 31(6):678-684. PubMed ID: 30633038
    [Abstract] [Full Text] [Related]

  • 14. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.
    Semin Liver Dis; 2011 Feb 07; 31(1):49-60. PubMed ID: 21344350
    [Abstract] [Full Text] [Related]

  • 15. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM.
    Histopathology; 2012 Dec 07; 61(6):1106-16. PubMed ID: 22882148
    [Abstract] [Full Text] [Related]

  • 16. Surgery of extrahepatic bile duct cancer - current evidence and recommendations.
    Nikov A, Gürlich R.
    Rozhl Chir; 2022 Dec 07; 101(9):416-420. PubMed ID: 36257799
    [Abstract] [Full Text] [Related]

  • 17. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM.
    Mod Pathol; 2014 Aug 07; 27(8):1163-73. PubMed ID: 24406866
    [Abstract] [Full Text] [Related]

  • 18. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, La Vecchia C, Negri E.
    J Hepatol; 2019 Jul 07; 71(1):104-114. PubMed ID: 30910538
    [Abstract] [Full Text] [Related]

  • 19. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
    Ercolani G, Dazzi A, Giovinazzo F, Ruzzenente A, Bassi C, Guglielmi A, Scarpa A, D'Errico A, Pinna AD.
    Eur J Surg Oncol; 2015 Sep 07; 41(9):1162-9. PubMed ID: 26095704
    [Abstract] [Full Text] [Related]

  • 20. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J.
    ANZ J Surg; 2002 Dec 07; 72(12):857-61. PubMed ID: 12485219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.